Story perspectives

New Nonhormonal Male Contraceptive Shows Promise in Mice

4/8/2026

Summary

Story summary

Cornell University researchers developed a nonhormonal male contraceptive using the small molecule inhibitor JQ1 that targets meiotic prophase I.
In male mice, JQ1 was administered for three weeks and caused a complete cessation of sperm production.
Discontinuing treatment restored normal sperm production within six weeks and produced healthy offspring.
The approach could be delivered via quarterly injections or patches and offers a reversible alternative to condoms and vasectomies.

1 of 1

Story summary

Cornell University researchers developed a nonhormonal male contraceptive using the small molecule inhibitor JQ1 that targets meiotic prophase I.
In male mice, JQ1 was administered for three weeks and caused a complete cessation of sperm production.
Discontinuing treatment restored normal sperm production within six weeks and produced healthy offspring.
The approach could be delivered via quarterly injections or patches and offers a reversible alternative to condoms and vasectomies.